Tekla Healthcare Investors is a closed-ended equity mutual fund launched and managed by Tekla Capital Management LLC. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the healthcare sector, including the biotechnology, medical devices, and pharmaceuticals industries. The fund primarily invests in growth stocks of small cap companies. It employs fundamental analysis with a focus on factors such as current or anticipated market position for services or products, experienced business management, recognized technological expertise, and the ability either to generate funds internally to finance growth or to secure outside sources of capital to create its portfolio. The fund benchmarks the performance of its portfolio against the NASDAQ Biotechnology Index, the S&P 500 Index, and the S&P 1500 Healthcare Index. It was previously known as H&Q Healthcare Investors. Tekla Healthcare Investors was formed on October 31, 1986 and is domiciled in the United States.
Industry, Sector and Symbol
Stock Exchange NYSE
Industry Investment offices, not elsewhere classified
Sub-IndustryN/A
SectorFinance
SymbolNYSE:HQH
CUSIPN/A
Phone617-772-8500
Debt
Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A
Price-To-Earnings
Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A
Sales & Book Value
Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A
Profitability
EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A
Miscellaneous
EmployeesN/A
Outstanding Shares40,650,000
Market Cap$919.47
Tekla Healthcare Investors (NYSE:HQH) Frequently Asked Questions
What is Tekla Healthcare Investors' stock symbol?
Tekla Healthcare Investors trades on the New York Stock Exchange (NYSE) under the ticker symbol "HQH."
How often does Tekla Healthcare Investors pay dividends? What is the dividend yield for Tekla Healthcare Investors?
Tekla Healthcare Investors announced a quarterly dividend on Wednesday, May 23rd. Shareholders of record on Friday, June 1st will be paid a dividend of $0.47 per share on Friday, June 29th. This represents a $1.88 annualized dividend and a yield of 8.32%. The ex-dividend date of this dividend is Thursday, May 31st. View Tekla Healthcare Investors' Dividend History.
What is the consensus analysts' recommendation for Tekla Healthcare Investors?
0 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Tekla Healthcare Investors in the last year. There are currently for the stock, resulting in a consensus recommendation of "N/A."
Who are some of Tekla Healthcare Investors' key competitors?
Some companies that are related to Tekla Healthcare Investors include DNP Select Income Fund Inc. Common Stock (DNP), Nuveen Municipal Value Fund (NUV), Adams Diversified Equity Fund (ADX), Tri-Continental (TY), Gabelli Equity Trust (GAB), Tortoise Energy Infrastructure (TYG), PIMCO Corporate&Income Opportunity Fund (PTY), Royce Value Trust (RVT), Liberty All-Star Equity Fund (USA), Apollo Investment (AINV), Hercules Capital (HTGC), Boulder Growth & Income Fund Inc common stock (BIF), PIMCO High Income Fund (PHK), AllianceBernstein Global Hgh Incm Fd (AWF) and General American Investors (GAM).
Who are Tekla Healthcare Investors' key executives?
Tekla Healthcare Investors' management team includes the folowing people:
- Dr. Daniel R. Omstead M.S, Ph.D., CEO, Pres & Trustee
- Ms. Kimberley L. Carroll, CFO, CFO - HQL Fund, VP & Treasurer of Hambrecht & Quist Capital Mgmt LLC
- Ms. Laura F. Woodward CPA, Chief Compliance Officer, Treasurer and Sec.
- Dr. Jason C. Akus M.D., MBA, VP of Research and Portfolio Mang.
- Mr. Christopher F. Brinzey MBA, Sr. VP of Research and Portfolio Mang.
Has Tekla Healthcare Investors been receiving favorable news coverage?
Press coverage about HQH stock has been trending somewhat positive recently, Accern reports. The research firm ranks the sentiment of press coverage by monitoring more than twenty million news and blog sources in real time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Tekla Healthcare Investors earned a daily sentiment score of 0.05 on Accern's scale. They also assigned news coverage about the financial services provider an impact score of 46.26 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the company's share price in the near term.
How do I buy shares of Tekla Healthcare Investors?
Shares of HQH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Tekla Healthcare Investors' stock price today?
One share of HQH stock can currently be purchased for approximately $22.59.
How big of a company is Tekla Healthcare Investors?
Tekla Healthcare Investors has a market capitalization of $919.47 million.
How can I contact Tekla Healthcare Investors?
Tekla Healthcare Investors' mailing address is 2 LIBERTY SQUARE 9TH FLOOR, BOSTON MA, 02109. The financial services provider can be reached via phone at 617-772-8500 or via email at [email protected]
MarketBeat Community Rating for Tekla Healthcare Investors (NYSE HQH)
MarketBeat's community ratings are surveys of what our community members think about Tekla Healthcare Investors and other stocks. Vote "Outperform" if you believe HQH will outperform the S&P 500 over the long term. Vote "Underperform" if you believe HQH will underperform the S&P 500 over the long term. You may vote once every thirty days.
